Scarica l'app Stockscreener
23.22
1.83%
-0.431
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
842,089 Shares in Nurix Therapeutics, Inc. $NRIX Bought by Bank of America Corp DE - MarketBeat
More than 5% of Nurix Therapeutics (NRIX) is reported by three parties, but one fund holds the shares. - Stock Titan
Trading Systems Reacting to (NRIX) Volatility - news.stocktradersdaily.com
Nurix Therapeutics, Inc. (NRIX) Stock Price, News, Quote & History - ca.finance.yahoo.com
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates - Zacks Investment Research
Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Gem With A 33% Upside Potential - DirectorsTalk Interviews
Behavioral Patterns of NRIX and Institutional Flows - news.stocktradersdaily.com
Nurix Therapeutics Stock Price Forecast. Should You Buy NRIX? - StockInvest.us
We Think Nurix Therapeutics (NASDAQ:NRIX) Can Afford To Drive Business Growth - Moomoo
Nurix Therapeutics, Inc. (NRIX) Latest Stock News & Headlines - Yahoo Finance
Here's Why You Should Add NRIX Stock to Your Portfolio Now - Yahoo Finance
Transcript : Nurix Therapeutics, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 03 - marketscreener.com
Nurix Therapeutics (NRIX) Upgraded to Buy: Here's Why - Yahoo Finance
Nurix Therapeutics (NRIX) Advances 0.50% to $26.26 as Shares Test Range Between Support and ResistanceWyckoff Spring - dars.gov.et
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum By Investing.com - Investing.com India
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum - investing.com
Legal & General Group Plc Buys Shares of 72,026 Nurix Therapeutics, Inc. $NRIX - MarketBeat
Wall Street Zen Downgrades Nurix Therapeutics (NASDAQ:NRIX) to Sell - MarketBeat
Bank of New York Mellon Corp Purchases New Shares in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics chief legal officer sells over $149k in shares By Investing.com - Investing.com South Africa
Braidwell LP Cuts Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Nurix Therapeutics chief legal officer sells over $149k in shares - Investing.com
The Manufacturers Life Insurance Company Acquires New Holdings in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Man Group plc Makes New $2.08 Million Investment in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Alyeska Investment Group L.P. Takes $3.35 Million Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix CSO Gwenn Hansen sells $36,982 in stock - Investing.com
Nurix Therapeutics (NASDAQ:NRIX) Insider Gwenn Hansen Sells 1,452 Shares of Stock - MarketBeat
Nurix Therapeutics to Participate in Upcoming September Investor Conferences - Investing News Network
BlackRock Inc. Buys New Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Deutsche Bank AG Takes Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
58,898 Shares in Nurix Therapeutics, Inc. $NRIX Bought by Polymer Capital Management HK LTD - MarketBeat
Nurix (NRIX) Financial Update: EPS Comes in Below Forecast; Stock Move: The Stock Loses 2.40%Annual Earnings Summary - careplusvn.com
Bank of America Corp DE Purchases 65,595 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer - Sahm
Edmond DE Rothschild Holding S.A. Invests $2.18 Million in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix (NRIX) Price: Ends Lower by 1.22% at $26.72 on the Day; Current Setup: Traders Can Monitor the $25.38-$28.06 Range in the Available RecordSector Neutral Pair - careplusvn.com
Deep Track Capital, LP Expands Nurix Therapeutics Inc (NRIX) Sta - GuruFocus
Top BridgeBio Oncology Therapeutics (BBOT) Competitors 2026 - MarketBeat
Press Release: Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer - Moomoo
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 12-Month HighShould You Buy? - MarketBeat
Nurix (NRIX) Results Review: The EPS Result Is Below Expectation for the Current Session; Post-Earnings: Shares Fall 0.88%EPS Growth Rate - Vinanet
Nurix Therapeutics (NRIX) Starts Phase 3 And Lands Sanofi Milestone, Is The Valuation About Right? - Sahm
Handelsbanken Fonder AB Buys 86,000 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics (NRIX) Is Up 6.0% After Milestone From Sanofi And Phase 3 Start With Roche - webull.com
Nurix Therapeutics stock hits 52-week high at $26.40 By Investing.com - Investing.com Nigeria
Nurix Therapeutics stock hits 52-week high at $26.40 - Investing.com
Sei Investments Co. Buys 46,132 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Understanding the Setup: (NRIX) and Scalable Risk - Stock Traders Daily
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
NRIX Maintained by RBC Capital -- Price Target Raised to $36 - GuruFocus
Royal Bank Of Canada Boosts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $36.00 - MarketBeat
4.04%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):